AbCellera acquires transmembrane protein producer; Compass gains psychedelic IP portfolio

Canadian antibody shop AbCellera acquired Massachusetts biotech TetraGenetics in an all-cash transaction. While more specific details were not made publicly available, AbCellera did say in a statement that the acquisition includes an upfront payment and potential milestone payments based on technical achievements, successful R&D and commercialization.


Click to view original post